Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00852 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCNF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NR2C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF111 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNKS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INPP5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELOVL7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNDC3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBRG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SART1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSHZ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VTI1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on